Browsing by Author Joon Seong Park
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
| 1-Jul-2018 | Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib | Sung Eun Lee; Soo Young Choi; Soo Hyun Kim; Saengsuree Jootar; Hyeoung Joon Kim; Sang Kyun Sohn; Joon Seong Park; Sung Hyun Kim; Dae Young Zang; Suk Joong Oh; Dong Wook Kim; Ajou University, School of Medicine; Kyungpook National University Hospital; Chonnam National University, College of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Dong-A University, College of Medicine; Samsung Group; Hallym University, College of Medicine; The Catholic University of Korea |
| 1-Jul-2014 | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors | Sung Hyun Kim; Hari Menon; Saengsuree Jootar; Tapan Saikia; Jae Yong Kwak; Sang Kyun Sohn; Joon Seong Park; Seong Hyun Jeong; Hyeoung Joon Kim; Yeo Kyeoung Kim; Suk Joong Oh; Hawk Kim; Dae Young Zang; Joo Seop Chung; Ho Jin Shin; Young Rok Do; Jeong A. Kim; Dae Young Kim; Chul Won Choi; Sahee Park; Hye Lin Park; Gong Yeal Lee; Dae Jin Cho; Jae Soo Shin; Dong Wook Kim; Dong-A University; Tata Memorial Hospital; Mahidol University; Prince Aly Khan Hospital; Chonbuk National University, School of Medicine; Kyungpook National University Hospital; Ajou University; Chonnam National University; SungKyunKwan University, School of Medicine; University of Ulsan, College of Medicine; Hallym University; Pusan National University, College of Medicine; Keimyung University, Dongsan Medical Center; The Catholic University of Korea; Korea University; IL-YANG Pharmaceutical Co., Ltd. |
| 1-Dec-2017 | Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia | Jae Yong Kwak; Sung Hyun Kim; Suk Joong Oh; Dae Young Zang; Hawk Kim; Jeong A. Kim; Young Rok Do; Hyeoung Joon Kim; Joon Seong Park; Chul Won Choi; Won Sik Lee; Yeung Chul Mun; Jee Hyun Kong; Joo Seop Chung; Ho Jin Shin; Dae Young Kim; Jinny Park; Chul Won Jung; Udomsak Bunworasate; Narcisa Sonia Comia; Saengsuree Jootar; Arry Harryanto Reksodiputro; Priscilla B. Caguioa; Sung Eun Lee; Dong Wook Kim; Chonbuk National University, School of Medicine; Dong-A University; SungKyunKwan University, School of Medicine; Hallym University; University of Ulsan, College of Medicine; The Catholic University of Korea; Keimyung University, Dongsan Medical Center; Chonnam National University; Ajou University; Korea University; Inje University Paik Hospital; Ewha Womans University School of Medicine; Wonju Severance Christian Hospital; Pusan National University, College of Medicine; Gachon University; Chulalongkorn University; Mary Mediatrix Medical Center; Mahidol University; University of Indonesia, RSUPN Dr. Cipto Mangunkusumo; St. Luke's Medical Center Quezon City |
